Breast Cancer Characteristics in the Population of Survivors Participating in the World Trade Center Environmental Health Center Program 2002-2019.
9/11
breast cancer
environmental exposure
exposure assessment
world trade center
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
15 07 2021
15 07 2021
Historique:
received:
30
04
2021
revised:
01
07
2021
accepted:
13
07
2021
entrez:
24
7
2021
pubmed:
25
7
2021
medline:
12
8
2021
Statut:
epublish
Résumé
The destruction of World Trade Center on 11 September 2001 exposed local community members to a complex mixture of known carcinogens and potentially carcinogenic substances. To date, breast cancer has not been characterized in detail in the WTC-exposed civilian populations. The cancer characteristics of breast cancer patients were derived from the newly developed Pan-Cancer Database at the WTC Environmental Health Center (WTC EHC). We used the Surveillance, Epidemiology, and End Results (SEER) Program breast cancer data as a reference source. Between May 2002 and 31 December 2019, 2840 persons were diagnosed with any type of cancer at the WTC EHC, including 601 patients with a primary breast cancer diagnosis (592 women and 9 men). There was a higher proportion of grade 3 (poorly differentiated) tumors (34%) among the WTC EHC female breast cancers compared to that of the SEER-18 data (25%). Compared to that of the SEER data, female breast cancers in the WTC EHC had a lower proportion of luminal A (88% and 65%, respectively), higher proportion of luminal B (13% and 15%, respectively), and HER-2-enriched (5.5% and 7%, respectively) subtypes. These findings suggest considerable differences in the breast cancer characteristics and distribution of breast cancer intrinsic subtypes in the WTC-exposed civilian population compared to that of the general population. This is important because of the known effect of molecular subtypes on breast cancer prognosis.
Identifiants
pubmed: 34300003
pii: ijerph18147555
doi: 10.3390/ijerph18147555
pmc: PMC8306152
pii:
doi:
Substances chimiques
Carcinogens
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, U.S. Gov't, P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NCI NIH HHS
ID : P30 CA016087
Pays : United States
Organisme : NCI NIH HHS
ID : P50 CA225450
Pays : United States
Références
Am J Epidemiol. 2011 Jan 1;173(1):26-37
pubmed: 21084553
JNCI Cancer Spectr. 2019 Nov 06;4(1):pkz090
pubmed: 32337498
Breast Cancer Res Treat. 2008 May;109(1):123-39
pubmed: 17578664
Genomics. 2020 Jan;112(1):388-396
pubmed: 30851359
J Clin Oncol. 2013 Jan 10;31(2):203-9
pubmed: 23233704
Environ Health Perspect. 2013 Jun;121(6):699-704
pubmed: 23613120
J Aging Health. 2012 Mar;24(2):323-44
pubmed: 21956096
Environ Health Perspect. 2003 Jun;111(7):972-80
pubmed: 12782501
Cancer Epidemiol. 2011 Oct;35(5):438-41
pubmed: 21227766
Environ Health Perspect. 2002 Jul;110(7):703-14
pubmed: 12117648
Cancer Epidemiol. 2016 Aug;43:63-9
pubmed: 27394678
BMC Cancer. 2020 Nov 23;20(1):1138
pubmed: 33228587
J Natl Cancer Inst. 2014 Apr 28;106(5):
pubmed: 24777111
Int J Cancer. 2008 Jan 1;122(1):165-9
pubmed: 17708572
Am J Ind Med. 2016 Sep;59(9):722-30
pubmed: 27582474
Am J Ind Med. 2016 Sep;59(9):709-21
pubmed: 27582473
N Engl J Med. 2006 Aug 10;355(6):560-9
pubmed: 16899776
Int J Environ Res Public Health. 2021 Feb 09;18(4):
pubmed: 33572220
Environ Health Perspect. 2004 May;112(6):731-9
pubmed: 15121517
Lancet. 2011 Sep 3;378(9794):898-905
pubmed: 21890054
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23
pubmed: 12829800
Am J Ind Med. 2016 Feb;59(2):96-105
pubmed: 26725936
J Occup Environ Med. 2015 Oct;57(10):e101-13
pubmed: 26461871
Int J Cancer. 2004 Sep 1;111(3):451-6
pubmed: 15221976
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602
Ann Am Thorac Soc. 2016 May;13(5):577-83
pubmed: 26872108
Int J Environ Res Public Health. 2020 Oct 01;17(19):
pubmed: 33019547
Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):619-626
pubmed: 29593010
Cancer Epidemiol Biomarkers Prev. 2005 Nov;14(11 Pt 1):2591-7
pubmed: 16284383
Ann N Y Acad Sci. 2006 Sep;1076:54-79
pubmed: 17119193
MMWR Surveill Summ. 2006 Apr 7;55(2):1-18
pubmed: 16601667
Breast. 2015 Nov;24 Suppl 2:S26-35
pubmed: 26253814
J Occup Environ Med. 2009 May;51(5):534-41
pubmed: 19365288
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
pubmed: 11553815